Health authorities in England have launched a vaccination campaign targeting approximately one million young people against meningitis B, a potentially life-threatening bacterial infection. The initiative was prompted by an outbreak in Kent earlier this year, which resulted in 29 confirmed or suspected cases and two deaths and has been characterized by officials as unprecedented and explosive.
The vaccination program is available to 17 and 18-year-olds in sixth form and students under age 25 entering residential universities or further education colleges for the first time in autumn 2026. Eligible groups include those born between September 1, 2007 and August 31, 2008, as well as individuals born on or after July 21, 2001 who are beginning higher education. International students and those from other parts of the UK studying in England also qualify. Nearly 90,000 doses have already been administered, with 135,000 additional appointments scheduled for the coming weeks.
The vaccine is being distributed through NHS pharmacies across England, with 17 and 18-year-olds able to book through the NHS National Booking Service if registered with a GP. Other eligible students can contact participating pharmacies, and walk-in appointments are available for those meeting age and enrollment criteria without requiring GP registration. The vaccine requires two doses administered at least 28 days apart for optimal protection.
Meningitis B can cause serious complications including inflammation of the brain lining, blood poisoning, and in severe cases death or permanent disabilities such as hearing loss and amputations. Young adults attending university have been identified as facing approximately seven times higher risk of infection compared to peers not pursuing higher education, largely due to increased social mixing and shared living arrangements. The MenB vaccine was added to routine childhood immunizations for babies born after July 1, 2015, but was not previously available to older teenagers and young adults.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI